Top Markets
Coin of the day
Halberd Corporation Halberd Corporation

Halberd Corporation

HALB
Rang in Aktien #39750
Halberd Corporation is a biotechnology firm dedicated to pioneering therapies... Halberd Corporation is a biotechnology firm dedicated to pioneering therapies for neurodegenerative conditions. The company's therapeutic focus encompasses a broad range of serious illnesses, including post-traumatic stress disorder (PTSD) and chronic traumatic encephalopathy (CTE), Alzheimer's disease, Parkinson's disease, various forms of cancer, and disorders impacting the blood and cerebrospinal fluid. Established in 2009, Halberd Corporation operates from its headquarters in Jackson Center, Pennsylvania.
Aktienkurs
$0.0007
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$361.11K
Veränderung (1 Tag)
-12.50%
Veränderung (1 Jahr)
-63.16%
Land
US
Handel Halberd Corporation (HALB)

Kategorie

Kursverlauf für Halberd Corporation (HALB)
Höchster Schlusskurs: $0.00 am 2026-08-01

Niedrigster Schlusskurs: $0.48 am 2009-06-01
Kursverlauf der Aktie von Halberd Corporation von 2009 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 0.00%
2025 -59.01%
2024 -26.40%
2023 -44.06%
2022 -53.41%
2021 -37.20%
2020 2,546.23%
2019 -49.94%
2018 113.17%
2017 -12.06%
2016 378.68%
2015 -95.10%
2014 124.21%
2013 -93.72%
2012 -48.03%
2011 559.64%
2010 -28.57%
2009 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$517.18 32.51%
US
$857.76 31.47%
NL
$745.22 9.11%
CH
$1.07K -6.40%
KR
$258.46 14.18%
BE